Clinical Trial Update: Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating intratympanic drug delivery for multiple forms of hearing loss has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meniere Disease
• Noise-induced Hearing Loss
• Ototoxic Hearing Loss
• Sudden Sensorineural Hearing Loss

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hearing Loss, Sudden, Hearing Loss, Ototoxic | Phase 1, Phase 2 | Status: COMPLETED